抗菌药物监督管理在ICU 中的应用效果

Abstract
Figure/Table
References (19)
Related Citation (15)

Download: PDF (0 KB) HTML (31 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the application effect of antibiotics supervision and management in ICU.Methods A total of 150 patients admitted to ICU, People′s Hospital of Yingde, Guangdong Province from January 2014 to January 2015 were selected retrospectively as the control group, and 150 patients admitted from February 2015 to February 2016 were selected as the intervention group. Routine management of the use of antibiotics was carried out in the control group, and supervision and management of antibiotics was carried out in the intervention group. The utilization rate, use intensity, microbial specimen submission rate and occurrence of drug-resistant bacteria infection were compared between the two groups. Results The utilization rate of antibiotics in the intervention group was lower than that in the control group, and the difference was statistically significant (P<0.05). The intensity of antibiotics use in the intervention group was (159.84±18.04) DDDs/(100 person·days), lower than that in the control group (215.37±22.86) DDDs/(100 person·days), and the difference was statistically significant (P<0.05). The rate of microbiological specimen submission was 72.13% in ICU of the intervention group, which was higher than 46.94% in the control group, and the difference was statistically significant(P<0.05).The incidence of drug-resistant bacteria infection in the intervention group was 2.67%,lower than 8.00% in the control group, and the difference was statistically significant (P<0.05). Conclusion The monitoring and management of antibiotics in ICU ward can reduce the frequency and intensity of antibiotics use, effectively improve the rate of microbial specimen submission, and reduce the occurrence of multi-drug resistant bacteria infection.

Key words： ICU Antibiotics Rational drug use Multiple resistant bacteria

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Qiu-ju
	ZHU Ya-rong
	PENG Guo-liang

Cite this article:

LI Qiu-ju,ZHU Ya-rong,PENG Guo-liang. Effect of antibiotic supervision and management in ICU[J]. 中国当代医药, 2021, 28(34): 170-172.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I34/170

[1]	Tacconelli E，Cataldo MA，Dancer SJ，et al.ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients[J].Clin Microbiol Infect，2014，20（1）：1-55.
[2]	刘丹华，张晓伟，张翀.抗生素滥用与超级细菌[J].国外医药（抗生素分册），2019，40（1）：1-4.
[3]	Hueston WJ，Dickerson L.Antibiotic resistance and the need for the rational use of antibiotics[J].J Med Liban，2001，49（5）：246-256.
[4]	朱亚容，彭国梁，罗君玲，等.优化抗菌药使用综合管理与ICU 耐药菌发生率相关性研究[J].中国医药科学，2019，9（2）：176-179.
[5]	王科冉.肺炎克雷伯菌感染患者治疗方案的合理性分析及药学干预效果评价[D].呼和浩特：内蒙古医科大学，2019.
[7]	卫生部办公厅关于印发《多重耐药菌医院感染预防与控制技术指南（试行）》的通知[J].中华人民共和国卫生部公报，2011，4（2）：59-61.
[8]	中华人民共和国卫生部.《医院感染诊断标准（试行）》[J].现代实用医学，2003，4（7）：460-465
[9]	赵怡鸿，曲海，王蕊，等.ICU 患者医院感染调查及多药耐药菌流行趋势分析[J].中华医院感染学杂志，2015，8（19）：4441-4443.
[10]	孙迎娟，王洪梅，刘淑红.ICU 患者多药耐药菌感染的监测与控制[J].中华医院感染学杂志，2015（20）：4691-4693.
[6]	Magiorakos AP，Srinivasan A，Carey RB，et al.Multidrug-resistant，extensively drug-resistant and pandrug-resistant bacteria：an international expert proposal for interim standard definitions for acquired resistance[J].Clin Microbiol Infect，2012，18（3）：268-281.
[11]	王斌.创伤骨科术后感染的流行病学调查及相关因素分析[D].兰州：甘肃中医药大学，2020.
[12]	贾会学，胡必杰，吴安华，等.多重耐药菌感染干预效果多中心研究[J].中国感染控制杂志，2015（8）：524-529.
[13]	章小敏，叶爱菊，罗良剑，等.ICU 细菌耐药性与抗菌药物使用强度的相关性研究[J].中华医院感染学杂志，2013，23（10）：2442-2444.
[14]	刘畅，贾启明，李振轩，等.ICU 细菌耐药性与抗菌药物使用强度的关联性研究[J].海峡药学，2018，26（2）：452-453.
[15]	Ruhnke M，Arnold R，Gastmeier P.Infection control issues in patients with haematological malignancies in the era of multidrug-resistant bacteria[J].Lancet Oncol，2014，15（13）：606-619.
[16]	孙毅东，林爱华，杨永强，等.2013 年某中医院ICU 抗菌药物使用情况与细菌耐药性的相关性研究[J].北方药学，2015，17（4）：112-114.
[17]	郭轶男，冯伟，刘露，等.ICU 强化感染控制措施对呼吸机相关性肺炎及多重耐药菌发生率的影响[J].中国实用乡村医生杂志，2017，24（10）：171-172.
[18]	齐野，任双颂，车颖，等.金属有机框架抗菌材料的研究进展[J].化学学报，2020，78（7）：613-624.
[19]	甄建斌.肽基聚合物的构建及其抗菌性能研究[D].西安：西北大学，2020.